ISOLATION AND CHARACTERIZATION OF BACTERIOPHAGE WITH LYTIC ACTIVITY AGAINST CARBAPENEM RESISTANCE STRAIN OF

Abeer Ameen Baqer1, Norefrina Shafinaz Md Nor2, Huda Salman Alagely3

  • 1BIOTECHNOLOGY DIVISION, DEPARTMENTS OF APPLIED SCIENCES, UNIVERSITY OF TECHNOLOGY, IRAQ.

Abstract

Insights

The lytic bacteriophage k3w7 shows potential for treating Klebsiella pneumoniae carbapenemase infections. This bacteriophage exhibits favorable characteristics for therapeutic applications against difficult-to-treat bacterial strains.

Area of Science:

  • Microbiology
  • Virology
  • Infectious Diseases

Background:

  • Klebsiella pneumoniae is a significant cause of hospital-acquired infections.
  • Carbapenemase-producing K. pneumoniae strains are increasingly prevalent and difficult to treat.
  • Bacteriophage therapy presents a promising alternative to antibiotics.

Purpose of the Study:

  • To characterize the lytic bacteriophage k3w7 for potential therapeutic use.
  • To evaluate the morphology, host range, life cycle, and stability of bacteriophage k3w7.
  • To assess the suitability of k3w7 for combating carbapenemase-producing K. pneumoniae.

Main Methods:

  • Isolation and characterization of bacteriophage k3w7 targeting Klebsiella pneumoniae kP2.
  • Transmission Electron Microscopy (TEM) for morphology assessment.
  • Plaque assays, restriction enzyme digestion, and stability tests (pH, temperature).

Main Results:

  • TEM revealed k3w7 possesses icosahedral heads (100 nm) and contractile sheaths (120 nm), characteristic of the Myoviridae family.
  • Phage growth cycle analysis showed a short latent period (20 min) and a burst size of ~220 PFU/cell.
  • k3w7 demonstrated stability across a broad pH and temperature range, with a 50-kb double-stranded DNA genome.

Conclusions:

  • Bacteriophage k3w7 exhibits robust characteristics suitable for phage therapy.
  • Its stability and lytic activity make it a viable candidate against carbapenemase-producing K. pneumoniae.
  • Further research into k3w7 could lead to novel treatments for multidrug-resistant infections.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.3K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
102
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.7K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
99